Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
about
Eradication of Helicobacter pylori for non-ulcer dyspepsiaEradication of Helicobacter pylori for non-ulcer dyspepsiaInflammation, atrophy, and gastric cancerPathogenesis of Helicobacter pylori infectionCagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rateOpen-access upper gastrointestinal endoscopy a decade after the introduction of proton pump inhibitors and helicobacter pylori eradication: a shift in endoscopic findings.Consequences of Helicobacter pylori infection in children.The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study.Patients with established gastro-esophageal reflux disease might benefit from Helicobacter pylori eradication.There is no difference in the disease severity of gastro-oesophageal reflux disease between patients infected and not infected with Helicobacter pylori.Assessing the risks and benefits of treating Helicobacter pylori infection.Review article: Helicobacter pylori and gastro-oesophageal reflux disease.Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter projectA novel therapeutic approach for Helicobacter pylori infection: the bismuth-based triple therapy monocapsule.Review article: gastro-oesophageal reflux disease and Helicobacter pylori infection.Review article: an approach to Helicobacter pylori infection in the elderly.Review article: gastro-oesophageal reflux disease--pathophysiological issues of clinical relevance.New strategies for the prevention and treatment of Helicobacter pylori infection.Helicobacter pylori infection in geriatrics.A rational approach to uninvestigated dyspepsia in primary care: review of the literature.Review article: Helicobacter pylori and reflux disease.Active and inactive gastroesophageal reflux diseases related to Helicobacter pylori therapy.Does a relationship still exist between gastroesophageal reflux and Helicobacter pylori in patients with reflux symptoms?Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjectsCure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trialEffect of Helicobacter pylori eradication on treatment of gastro-oesophageal reflux disease: a double blind, placebo controlled, randomised trialEffect of Helicobacter pylori Eradication on the Development of Reflux Esophagitis and Gastroesophageal Reflux Symptoms: A Nationwide Multi-Center Prospective StudyNatural history of gastro-oesophageal reflux disease: the neglected factor.Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease.Assessment of reflux symptom severity: methodological options and their attributes.Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects.Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.Relationship between Helicobacter pylori infection and gastroesophageal reflux disease.The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique.Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patientsHelicobacter pylori: present status and future prospects in Japan.Population-based assessment of heartburn in urban Black Americans.
P2860
Q24234277-F5C5412F-A70F-414F-B932-5676BD774EB7Q24246018-21AB611F-2C4C-47E3-A604-A763ADEE2566Q24676709-B7CF3954-D6CD-4D73-A585-70616712116AQ24679810-36E2D120-A4E2-4983-A4A7-38752383DAD7Q25257847-C0AE2C2E-DFFC-4626-85BD-157112F50A3FQ30483600-7BDDCC10-9D98-439E-B150-AAB48AA4F7C8Q33392675-BFEADCD3-D149-406B-BB0B-19020706BA0BQ33695532-3B78F6B2-1357-44E3-BC5F-49442D618B89Q34303140-BA3DFE1B-340D-4F0C-8DC9-6B4D25CAC512Q34349833-C070F887-70C2-4313-952D-2AF6ED18EA6EQ34408985-82A38CAC-D33D-463B-A650-33EA908B7A45Q34436774-AD2FC9E1-9098-457C-B23E-FC322273928FQ34444139-445674D2-CC51-4F71-B4A4-4A9CB2CBE054Q34481671-E2DAF100-7AAB-4B93-AF08-900B2A1543DDQ34534346-E928DE22-A08F-4DC7-A6A1-9B09F92AB1B5Q34585332-0ABFF06C-7784-4389-A909-682EFD748988Q34669257-4A0972F2-9D1E-4173-9D3B-D50CE938989BQ34768573-EBA76AC7-85D8-4971-981F-7A57DF2DE4B3Q34799624-1D4BBA8D-64E7-4940-A38E-6F1D9C025ECDQ35037626-02CD26B1-9212-4D7C-B79E-52D9E2D8A7BAQ35058182-4CCA0724-A0D9-4D0D-B169-D3E7377601A8Q35209726-F0CAF267-1215-4FBF-A098-EBB4BFFDAF6EQ35409960-B8C561C5-5315-44D0-BF2A-61B60FD236CDQ35596051-BC0410E5-152C-4CB2-883B-8AA5E8B06F61Q35596265-FEFA96AE-64D2-4BC6-BB08-5370C555F76DQ35598239-2DD6E7D7-E153-4B2D-8500-F927FCC33A05Q35619147-9DCC4986-0529-4FD3-9D3C-604351C939E9Q35642463-F050D7D6-4828-40B1-B8E6-D11B211A9014Q35687664-05A9762B-B3FB-4B6B-8010-63F75C5D7129Q35745038-95371E09-587B-4862-AA8B-D0658C8CC580Q35761321-667E83EA-0F35-49A2-A80F-4AE3F5434E8AQ35893211-B3A1A061-C69D-40C0-9E14-8AA82E39D535Q35990765-34ADEF9E-0715-4AAC-95EC-DAC4A9BD9DFCQ36041651-CA647DF2-52EC-427E-A948-2D5D58C9256DQ36243482-7BC091C2-717E-407B-B4A7-4504758F34C5Q36376528-4E9D825C-2042-48B0-A61A-38518C166AFFQ36575935-ADAB211A-70F4-4C5E-A4F0-51F0C152DE10Q36578916-486DF01D-23EE-4ED5-81AB-703CBDCAADF8Q36745437-AD696639-47D7-4DF4-BF3E-0E6055BC6847Q36881298-B14DAE96-05A8-419C-991E-BDA59173D24E
P2860
Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Helicobacter pylori and sympto ...... a randomised controlled trial.
@ast
Helicobacter pylori and sympto ...... a randomised controlled trial.
@en
Helicobacter pylori and sympto ...... a randomised controlled trial.
@nl
type
label
Helicobacter pylori and sympto ...... a randomised controlled trial.
@ast
Helicobacter pylori and sympto ...... a randomised controlled trial.
@en
Helicobacter pylori and sympto ...... a randomised controlled trial.
@nl
prefLabel
Helicobacter pylori and sympto ...... a randomised controlled trial.
@ast
Helicobacter pylori and sympto ...... a randomised controlled trial.
@en
Helicobacter pylori and sympto ...... a randomised controlled trial.
@nl
P2093
P1433
P1476
Helicobacter pylori and sympto ...... a randomised controlled trial.
@en
P2093
G Cathomas
I Guldenschuh
M Thumshirn
W Schwizer
P304
P356
10.1016/S0140-6736(00)04894-7
P407
P577
2001-06-01T00:00:00Z